- Home
- COYA
as 08-15-2025 4:00pm EST
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
| Founded: | 2020 | Country: | United States |
| Employees: | N/A | City: | HOUSTON |
| Market Cap: | 107.0M | IPO Year: | 2022 |
| Target Price: | $16.50 | AVG Volume (30 days): | 59.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.25 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.65 - $10.24 | Next Earning Date: | 08-12-2025 |
| Revenue: | $423,452 | Revenue Growth: | -95.57% |
| Revenue Growth (this year): | 40.52% | Revenue Growth (next year): | -53.02% |
Latest Coya Therapeutics Inc. News
COYA Breaking Stock News: Dive into COYA Ticker-Specific Updates for Smart Investing
ACCESS Newswire
2 months ago
iAccess Alpha's Virtual Best Ideas Summer Investment Conference June 24-25, 2025
Business Wire
2 months ago
Coya Therapeutics to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24 – 25, 2025
Business Wire
2 months ago
Coya Therapeutics Announces Issuance of New U.S. Patent Protecting Methods of Producing Recombinant Human (rh) Interleukin-2 (aldesleukin) Liquid Formulations
Simply Wall St.
3 months ago
Coya Therapeutics First Quarter 2025 Earnings: Misses Expectations
Business Wire
3 months ago
Coya Therapeutics to Participate at the H.C. Wainwright 3rd Annual BioConnect Investor Conference
Business Wire
3 months ago
Coya Therapeutics Reports First Quarter Financial Results and Provides a Corporate Update
Business Wire
3 months ago
Coya Therapeutics to Participate in Two Upcoming Conferences in May 2025
Zacks
4 months ago
Is Coya Therapeutics, Inc. (COYA) Outperforming Other Medical Stocks This Year?
Compare COYA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "COYA Coya Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.